| c-TACE | Conventional TACE (using Lipiodol®) |
| DEB-TACE | Drug-eluting bead TACE |
| RECIST | Response evaluation criteria in solid tumors |
| NET | Neuroendocrine tumor |
| OS | Overall survival |
| mRECIST | Modified response evaluation criteria in solid tumors |
| SSAs | Somatostatin analogs |
| TACE | Transarterial chemoembolization |
| TTLP | Time to liver progression |
| TTUP | Time to untreatable progression |
| WHO | World Health Organization |